Intra-Cellular Therapies Inc. (ITCI)

Intra-Cellular Therapies Inc. (ITCI $131.87)
- $131.87 Cap: $14.02B
- View ITCI Profile
- View Questions on ITCI

{tplLang.businessdescription | toLang tLang}

{ profileData.description }

{tplLang.details | toLang tLang}

{tplLang.ceo | toLang tLang}

{profileData.profile.details.ceo}

{tplLang.employees | toLang tLang}

{profileData.profile.details.employees | numeraljs '0,0'}

{tplLang.issuetype | toLang tLang}

{profileData.profile.details.issuetype | asIssueType}

{tplLang.industryclassifications | toLang tLang}

{tplLang.sector | toLang tLang}

{profileData.profile.classification.sector}

{tplLang.industry | toLang tLang}

{profileData.profile.classification.industry}

{tplLang.toolname| toLang tLang}

There is no {tplLang.toolname| toLang tLang} currently available for {data.symbolstring}.

Teladoc Health Inc. (TDOC $8.63)
- $8.63 Cap: $1.54B
- View TDOC Profile
- View Questions on TDOC
Acadia Healthcare Company Inc. (ACHC $21.50)
- $21.50 P/E (TTM): 15.14X Cap: $2.12B
- View ACHC Profile
- View Questions on ACHC
Intra-Cellular Therapies Inc. (ITCI $131.87)
- $131.87 Cap: $14.02B
- View ITCI Profile
- View Questions on ITCI
Magellan Health Inc. (MGLN)
- P/E (TTM): 8.41X Cap: $2.50B
- View MGLN Profile
- View Questions on MGLN
CloudMD Software & Services Inc. (DOC $0.04)
- $0.04 Cap: $10M
- View DOC Profile
- View Questions on DOC

Q: Following the pandemic there is a significant increase in mental health issues. Would you suggest any company or companies which are helping in addressing this issue and which you think have a good opportunity to grow. Thanks.

Regards,

Shyam

Read Answer Asked by Shyam on August 18, 2021